09:06 AM EDT, 04/28/2025 (MT Newswires) -- ADMA Biologics ( ADMA ) said Monday it has received approval from the US Food and Drug Administration for its yield enhancement production process.
The process is expected to raise production by roughly 20% from the same starting plasma volume, the biopharmaceutical company added.
ADMA's stock rose 12% in recent Monday premarket activity.